Of note, BRAF variations coexist with TERT promoter mutations both in melanoma and in thyroid cancer (Dubbink et al., 2014; Liu et al., 2014; Xing et al., 2014; Shi et al., 2015; Jin et al., 2016). This evidence concerns the gene BRAF and melanoma.